Porphirya cutanea tarda (PCT) has been reported in HIV-1-infected individuals [1,2]. It has been related to HIV [1,2], other viral infections (hepatitis C virus; HCV) [3] alcohol abuse and antiretroviral therapy (ART) [4,5]. We describe for the first time a case of PCT that developed during ART switch, after the introduction of tipranavir/ ritonavir to a backbone with tenofovir and lamivudine.
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report
NUNNARI G;
2007-01-01
Abstract
Porphirya cutanea tarda (PCT) has been reported in HIV-1-infected individuals [1,2]. It has been related to HIV [1,2], other viral infections (hepatitis C virus; HCV) [3] alcohol abuse and antiretroviral therapy (ART) [4,5]. We describe for the first time a case of PCT that developed during ART switch, after the introduction of tipranavir/ ritonavir to a backbone with tenofovir and lamivudine.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
